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ABSTRACT 
Background and purpose: To establish post-stroke case-fatality rates within a community 
based incident stroke population in rural Tanzania.   
Methods: Incident stroke cases were identified by the Tanzanian Stroke Incidence Project 
(TSIP), and followed up over the next 3 to 6 years. In order to provide a more complete 
picture we also used verbal autopsy (VA) to identify all stroke deaths occurring within the 
same community and time period, and identified a date of stroke by interview with a relative 
or friend. 
Results: Over 3 years TSIP identified 130 cases of incident stroke, of which 31 (23.8%, 95% 
CI 16.5 to 31.2) died within 28 days and 78 (60.0%, 95% CI 51.6 to 68.4) within 3 years of 
incident stroke.  Over the same time period, an additional 223 deaths from stroke were 
identified by VA, 64 (28.7%, 95% CI 20.9 to 36.5) had died within 28 days of stroke and188 
(84.3%, 95% CI 78.1 to 90.6) within 3 years.   
Conclusions: This is the first published study of post-stroke mortality in sub-Saharan Africa 
(SSA) from an incident stroke population.  The 28-day case-fatality rate is at the lower end of 
rates reported for other low and middle income countries, even when including those 
identified by VA, although confidence intervals are wide.  Three-year case-fatality rates are 
notably higher than seen in most developed world studies.  Improving post-stroke care may 
help to reduce stroke case-fatality in SSA. 
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INTRODUCTION 
Stroke is a major cause of death worldwide accounting for nearly 10% of all deaths, with 
85% of all stroke deaths occur in the developing world.[1]  Stroke incidence and case-fatality 
vary widely from country to country, but recent research, based on best available evidence, 
has supported the view that both are closely linked to measures of a country’s wealth, such as 
gross domestic product.[2-3]  Eastern Europe, north Asia, south Pacific and central Africa 
had the highest stroke mortality rates.  There was a 3.5-fold increase in stroke mortality in 
low-income countries compared to middle- and high-income countries.  Furthermore, stroke 
mortality has been shown to increase as economic conditions deteriorate; this increase is 
thought to be linked to increased case-fatality, rather than increased incidence.[4-5]   
 
The World Health Organisation’s MONICA study from the period 1980-1995 demonstrated 
mean 28-day case-fatality rates of 18% in Sweden, 19% in Denmark, 21% in Finland, 28% in 
Beijing, China, 33% in Italy, 40% in Russia and 45% in Poland.[5]  A 2009 systematic 
review of 56 population-based stroke incidence studies from 1970-2008 revealed a mean 
decrease in 1-month case-fatality between 1980-89 and 2000-08 from 21.5% to 19.8% in 
high income countries and from 35.2% to 26.6% in low to middle income countries.[3]  This 
decrease has occurred against a background of demographic changes leading to an 
increasingly elderly population, and is almost certainly due to improved management of 
stroke survivors.[6,7]  Declines in 1-year case-fatality have also been reported recently.[8]  In 
contrast, a long-term study in Oxfordshire, UK saw no significant change in incident stroke 
case-fatality from 1981 to 2004 (17.2% vs. 17.8%), despite a dramatic fall in overall 
incidence.[9]  Results from long-term follow-up of stoke cases are more variable, in part due 
to varying exclusion and inclusion criteria.[10-13]  However, recent studies from the 
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developed world suggest 3- and 5-year case-fatality rates of 43-54% and 53-60% 
respectively.[14-18] 
 
Reports of post-stroke deaths in sub-Sahara Africa (SSA) are, however, unreliable due to 
factors such as, the small number of deaths occurring in hospitals, limited death certification 
and lack of coverage of primary health care services.[19-20]  Previous studies looking at 
mortality amongst those admitted to hospital have demonstrated a one month case-fatality of 
between 27% and 46%.[21-23] 
 
We are not aware of any previous studies of case-fatality of incident stroke cases in SSA.[19]  
The aim of this study was to establish case-fatality over 3 years post-stroke within an incident 
population.  Such data are needed to help inform clinicians, government agencies and other 
healthcare providers in SSA.[2-3]  
 
PARTICIPANTS AND METHODS 
Participants were part of a stroke incidence study, details of which have been described 
previously.[24]  A favourable ethical opinion was obtained from the National Institute of 
Medical Research in Tanzania and from the Newcastle and Northumberland Joint Ethics 
Committee, UK.   
 
Recruitment 
During the incidence phase of our study we used two methods of case ascertainment.[24]  
The Tanzanian Stroke Incidence Project (TSIP) combined with verbal autopsy (VA) recruited 
cases from 15th June 2003 until 15th June 2006 and was conducted in two demographic 
surveillance sites (DSS); 52 villages in the Hai district of northern Tanzania and 8 
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geographical divisions of the city of Dar-es-Salaam.  The study described here is based on 
data from the Hai DSS.  Due to poorer coverage of primary healthcare services in the Dar-es-
Salaam DSS we were unable to follow-up all these cases.  The Hai DSS has been described 
previously as part of the Adult Morbidity and Mortality Project (AMMP).[25]  From within a 
population of 159,814, a total of 453 strokes were recorded in Hai during this time period, 
132 identified by TSIP and 346 by VA, with 25 cases identified by both systems.  The age-
adjusted incidence was 108.6 per 100,000 (95% CI 89.0 to 130.9).   
 
Tanzanian Stroke Incidence Project 
All 132 patients were followed-up prospectively after recruitment by a network of key 
informants within the DSS.  The names and addresses of the deceased were communicated to 
clinical officers who established the likely cause, place and date of death by discussion with 
relatives.  The results reported here relate to follow-up until 15th June 2009 (3-6 years post 
stroke depending on date of recruitment).   
 
Verbal autopsy  
The system of VA used has been well described and validated previously.[25-26]  It is 
described briefly here.  All deaths occurring in the study site were picked up as part of a long 
established system for VA and those identified as being due to stroke within the study period 
were included in the study.  Deaths are coded independently by two coders and in case of 
disagreement a third coder’s opinion is sought and the majority diagnosis recorded. To avoid 
double-counting we linked deaths within the study period occurring in patients identified by 
TSIP, with VA data using a variety of characteristics, including name and age, to determine 
the matches. All data were double entered into an EPI INFO data entry system. Fifteen 
percent of VAs from the study period had no cause of death ascribed, due to loss of forms. 
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For these we imputed a cause of death by randomly selecting (without replacement) from a 
pool of deaths from the same age, sex and area group as the missing deaths from one year 
before and one year after the year of the missing death. This process left the cause-specific 
mortality structure unchanged.  Cause of death was assigned by applying the International 
Classification of Diseases 10 (ICD-10) to determine the underlying cause of death.[27]  
Stroke deaths in the VA system were defined as those where the probable cause of death was 
a cardiovascular disorder (cerebrovascular disease and hypertension) excluding unspecified 
cardiovascular disorders, congestive cardiac failure and ischaemic heart disease.   
 
The date of the occurrence of the stroke was recorded as part of the VA, enabling fatality 
after 28 days and 3 years to be computed. 
 
Statistics 
Confidence intervals (CIs) for percentages are based on the normal approximation to the 
binomial distribution.  A Kaplan-Meier survival curve is presented. All cases still alive at the 
end of the study period are censored.  This means that data for the entire 6 years of the study 
can be considered, with data for those dying at greater than the minimum 3 years follow-up 
used.  
 
RESULTS 
Tanzanian Stroke Incidence project 
Only one case of subarachnoid haemorrhage was identified by CT head scan.  This patient, 
who died after 10 days, is excluded from further analysis because it was felt that the 
difference aetiology and prognosis of SAH would make this patient un-representative of the 
cohort as a whole. 
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By 15th June 2009, 87 cases, from 131, (66.4%, 95% CI 58.3 to 74.5) had died.  For 79 cause 
of death was recorded as stroke, or complications of stroke, including all cases that died 
within the first four weeks post-stroke.  One died from tumour, 3 from pneumonia and 3 from 
sepsis.  Fifty-one cases (58.6%) died at home, 21 (24.1%) at the local referral hospital, 
Kilimanjaro Christian Medical Centre (KCMC), 12 (13.8%) at Machame hospital and 3 
(3.4%) at other local hospitals. 
 
For one patient date of death was not known and this patient was excluded from further 
analysis.  For those in whom date of death was known (n = 86), the median time to death was 
101 days (range 0-1765).  Case-fatality rates are presented in Table 1 and the mean ages of 
those dead and alive at 28 days and 3 years in Table 2.  A Kaplan-Meier survival curve is 
shown in Figure 1. 
 
Of those identified by TSIP, 63 cases had a CT scan carried out within 15 days of incident 
stroke.  Eleven (175%) had evidence of a haemorrhagic stroke and 52 (825%) were normal 
or had evidence of cerebral infarct.  Although there was a difference in case-fatality between 
stroke sub-types at 28 days, with 3 deaths after haemorrhagic stroke (27.3%) and 10 
subsequent to cerebral infarct (19.2%) this did not reach statistical significance (95% CI for 
difference in percentage -20.3 to 36.5).  Three-year case-fatalities were 4 (36.4%) for 
haemorrhage and 26 (50.0%) for infarct (95% CI for the difference -17.9 to 45.1).   
 
Verbal Autopsy 
Excluding cases also identified by TSIP (n = 25), 321 stroke cases were identified by VA 
during the study period.  As previously reported, for some cases a cause of death had to be 
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imputed due to loss of VA forms.[24]  These cases (n = 29) are excluded from further 
analysis.  Furthermore, no reliable date of stroke could be established in 69 cases.  In some 
cases identified by the VA system, the stroke occurred before the start of the study period, but 
these cases should be balanced by those who had a stroke within the study period, but who 
died after the end of the study, and were therefore not include in the final figures.  For the 
remaining 223 cases for which a date of stroke was available (69.5% of all unique VA cases), 
the timing of death, worst case scenario (as by definition all these cases died eventually) 28-
day and 3-year ‘case-fatality rates’, are presented in Table 1 and age- and sex-specific case-
fatality rates at 28 days and 3 years in Table 2 and Table 3 respectively. 
 
Case-fatality rates for our cohort are compared to those from other studies in SSA (primarily 
based on hospital-ascertained cohorts) and Europe in Table 4. 
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Table 1. Three-year case-fatality rates for Hai DSS 
 Case-fatality rates for 130 cases (69 male, 
53.1%) identified by TSIP 
Timing of death for the 223 cases (114 male, 
51.1%) identified by VA (95% CI) 
Combined ‘Case-fatality rates’ for 353 cases (183 
male, 51.8%) identified by TSIP and VA (95% CI) 
Deaths Percentage (95% CI) Deaths Percentage (95% CI) Deaths Percentage (95% CI) 
7 days 16 (5 males) 12.3 (6.6 to 18.0) 51 (23 males) 22.9 (15.7 to 30.1) 67 (28 males) 19.0 (12.2 to 25.7) 
28 days 31 (15 males) 23.8 (16.5 to 31.2) 64 (31 males) 28.7 (20.9 to 36.5) 95 (46 males) 26.9 (19.3 to 34.5) 
6 months 48 (25 males) 36.9 (28.6 to 45.2) 117 (61 males) 52.5 (43.9 to 61.1) 165 (86 males) 46.7 (38.2 to 55.3) 
1 year 59 (32 males) 45.4 (36.8 to 53.9) 143 (75 males) 64.1 (55.9 to 72.4) 202 (107 males) 57.2 (48.7 to 65.7) 
2 years 73 (39 males) 56.2 (47.6 to 64.7) 167 (87 males) 74.9 (67.4 to 82.3) 240 (126 males) 68.0 (60.0 to 76.0) 
3 years 78 (42 males) 60.0 (51.6 to 68.4) 188 (99 males) 84.3 (78.1 to 90.6) 266 (141 males) 75.4 (67.9 to 82.8) 
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Table 2.  Age- and sex-specific case fatality rates at 28 days post-stroke  
 Cases identified by TSIP Cases identified by VA 
 Males Females Males Females 
 Number of deaths/total cases (%) Number of deaths (%) Number of deaths (%) Number of deaths (%) 
0-44 years 0/3 (0%) 1/6 (16.7%) 2/4 (50.0%) 3/13 (23.1%) 
45-54 years 2/6 (33.3%) 0/5 (0%) 2/8 (25.5%) 4/11 (36.4%) 
55-64 years 4/10 (40.0%) 3/11 (27.3%) 2/14 (14.3%) 2/11 (18.2%) 
65-74 years 3/22 (13.6%) 5/18 (27.8%) 5/35 (14.3%) 8/24 (33.3%) 
75-84 years 5/21 (23.8%) 3/8 (37.5%) 15/42 (35.7%) 9/32 (28.1%) 
≥ 85 years  1/7 (14.3%) 4/13 (30.8%) 5/11 (45.5%) 7/18 (38.9%) 
Overall 15/69 (21.7%)  16/61 (26.2%) 31/114 (27.2%) 33/109 (30.3%) 
Mean age (years) at stroke of those dead 70.5 (95% CI 65.8 to 75.2) 71.3 (95% CI 67.0 to 75.6) 
Mean age (years) at stroke of those alive 68.2 (95% CI 65.1 to 71.2) 69.7 (95% CI 67.5 to 72.0) 
* Ages given are at time of stroke. 
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Table 3.  Age- and sex-specific case fatality rates at 3 years post-stroke  
 Cases identified by TSIP Cases identified by VA 
 Males Females Males Females 
 Number of deaths/total cases (%) Number of deaths (%) Number of deaths (%) Number of deaths (%) 
0-44 years 1/3 (33.3%) 2/6 (33.3%) 4/4 (100.0%) 8/13 (61.5%) 
45-54 years 4/6 (66.7%) 2/5 (40.0%) 6/8 (75.5%) 7/11 (63.6%) 
55-64 years 5/10 (50.0%) 6/11 (54.5%) 11/14 (78.6%) 8/11 (72.7%) 
65-74 years 10/22 (45.5%) 12/18 (66.7%) 29/35 (82.9%) 20/24 (83.3%) 
75-84 years 16/21 (76.2%) 5/8 (62.5%) 40/42 (95.2%) 30/32 (93.8%) 
≥ 85 years 6/7 (85.7%) 9/13 (69.2%) 9/11 (81.8%) 16/18 (88.9%) 
Overall 42/69 (60.9%)  36/61 (26.2%) 99/114 (86.8%) 89/109 (81.7%) 
Mean age (years) at stroke of those dead 71.2 (95% CI 68.0 to 74.3) 71.6 (95% CI 69.5 to 73.7) 
Mean age (years) at stroke of those alive 65.0 (95% CI 60.7 to 69.4) 62.5 (95% CI 57.1 to 67.9) 
* Ages given are at time of stroke. 
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Table 4. Reported case-fatality rates in other populations 
 Number of 
participants 
Mean age in 
years (std dev.) 
Males (%) City or area Participants Case fatalities 
≤  1 month 1 year > 1 year 
Walker, et al 2003
21 
106 58 (16) 70 (66.0) Banjul, Gambia Hospital based 27% (1 month) 44% (6 
months) 
73.5% (3 years) 
Garbusinski, et al 
2005
23 
148 Median 64 73 (49.3) Banjul, Gambia Hospital based 46% (1 month) 58% (6 
months) 
62% (1 year) 
- 
Rosman, et al 
1986
22 
116 - 65 (56.0) Pretoria, South 
Africa 
Hospital based 33.6% (1 month) - - 
Komolafe, et al 
2007
34
 
293 - - Ile-Ife, Nigeria Hospital based 27.5% (7 days) 
45% (1 month) 
- - 
Osuntokum, et al 
1979
28 
318 - 229 (72.0) Ibadan, Nigeria Hospital and 
nursing home 
based 
34.9% (3 weeks) - - 
Bamford, et al 
1990
35
 
675 - 318 (47.1) Oxford, UK Incident cases 19% (30 days) 31% - 
Brønnum-Hansen, 
et al 2001
17 
4162 - 2187 (52.5) Copenhagen, 
Denmark 
Incident cases 28% (28 days) 41% 60% (5 years) 
Hankey et al 2000
16 
362 73 (13) 194 (53.6) Perth, Australia Incident cases 23% (30 days) 36% 58% (5 years) 
Mohan et al 2009
18 
2874 - 1427 (49.7) London, UK Incident cases - 36% 53% (5 years) 
Loor et al 1999
15 
221 - - Amsterdam, The 
Netherlands 
Community-based 
cohort 
26% (1 month) 37% 54% (3 years) 
Elneihoum et al 
1998
14 
2290 76 (11) 1051 
(45.9%) 
Malmö, Sweden Stroke register - - 43% (3 years) 
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Figure 1. Kaplan-Meier cumulative survival function for 3-6 years follow-up. 
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DISCUSSION 
This is the first study in SSA of post-stroke case-fatality in an incident stroke population.  
Previous studies of stroke mortality in SSA have tended to be hospital-based and have 
reported higher death rates (see Table 4), although long-term follow-up is often hampered by 
the inability to trace patients.[28]  It is notable that almost 60% of deaths within the TSIP 
identified cohort were at home, rather than in hospital.  Our lower case-fatality may reflect 
the fact that many cases of stroke in SSA are not reported.  This may be due to a number of 
reasons, both economic and cultural.[29]  Some strokes resulting in death soon after onset 
may not be recorded as stroke whilst some strokes will occur without formal diagnosis, with 
those with the more severe symptoms more likely to be admitted to hospital.  Moreover, 
many people may choose to visit traditional pharmacies and healers for advice rather than 
seeking help from more formal healthcare services.[29]  However, within TSIP efforts were 
made to identify stroke cases within the community and the project paid for transport to 
hospital, admission and investigative tests.   
 
Tanzania is one of the poorest countries in the world and there is limited access to 
rehabilitation services.[30]   However, post-stroke mortality for the combined TSIP and VA 
data at one month post-stroke in the Hai DSS bear comparison with those from many studies 
from the developed world.[3,5]  However, mortality rates at 3-years post-stroke, with over 
three-quarters of all cases having died, are noticeably higher.[14-15]  This is also apparent 
when considering the case-fatality rates from the TSIP data only.  Indeed, follow-up of 
incident stroke cases from 4 independent studies in the UK and Australia report lower 5-year 
case-fatality rates than seen at 3 years post-stroke in our study.[12,16,18,31]  This may 
suggest that case-fatality rates at one month post-stroke are governed to a large extent by the 
nature of the stroke itself.  Although death rates at 3 years may be influenced, in part, by the 
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life expectancy of the background population, they may also suggest that long-term mortality 
may be reduced by more effective post-stroke care. 
 
At 28 days, of those recruited to TSIP who underwent CT head scan at less than 15 days post-
stroke, haemorrhagic stroke was associated with a greater case-fatality rate than cerebral 
infarct, although the numbers were small and the difference did not reach statistical 
significance.  These findings support previous hospital-based studies in SSA.[32]  They are 
also broadly similar to those reported by Feigin et al in a systematic review of population-
based incidence studies.[3] 
 
The data in Table 2 reveal no significant difference in ages between those who had died, and 
those who were still alive, at 28 days post-stroke.  At 3 years post-stroke (Table 3), those 
who were dead were older at the time of stroke than those still alive, though this is only 
significant in those identified by VA.  Clearly for many of those dying some time after the 
incident stroke, the stroke itself is less likely to have been the direct cause of death than 
complications of the stroke or other co-morbidity.  However, this study was designed to 
estimate post-stroke mortality, regardless of the primary cause of death.  Without a suitable 
control population we are unable to comment on how many deaths may have been unrelated 
to the incident stroke. 
 
It would be inappropriate to consider the VA data as representing a direct measure of case-
fatality rates; rather it is the distribution of the duration between stroke and death.  
Nevertheless, it provides a ‘worst case scenario’ as these figures are based only on stroke 
deaths, and we have no way of knowing how many incident cases of stroke, which were not 
picked up by TSIP, survived, though this is likely to be very few.  Inclusion of the VA data 
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therefore provides a sensitivity analysis, giving extremes based on the experience within the 
community for the case-fatality rates. 
 
We acknowledge that the VA system is not ideal for identifying time from stroke to death.  
The system was designed to identify the cause of death by interview with close family 
members, friends or carers.  Where stroke was thought to be the primary cause of death, 
questions were asked about the date of onset of symptoms, weakness and paralysis to try to 
identify the date of stroke.  We recognise that this information, gathered retrospectively, 
relies heavily on the recall of those interviewed for the VA, and, therefore, may be 
inaccurate.  Nevertheless, we feel that the inclusion of these data adds substantially to the 
external validity of our findings, and provides a valuable sensitivity analysis – providing an 
estimate of the worst case scenario for 28-day and 3-year case-fatality rates.   
Given the lack of previous comparable data from SSA we are unable to comment on long-
term trends in post-stroke mortality.  Globally, case-fatality rates from stroke and 
cardiovascular disease appear to be linked to measures of prosperity, with recent research 
indicating an increase in rates in Eastern Europe in the last 20 years.[2-5, 33] 
 
Our results reveal that one-month case-fatality rates for the Hai district of Tanzania are 
similar to those reported for many low and middle income countries.  Further research is 
needed to establish whether this is representative of Tanzania, and SSA, as a whole.  In those 
surviving beyond one month post-stroke, effective management may help to reduce long-term 
mortality, but it is not clear how this should best be provided in a resource poor environment.  
For example, with the lack of sufficiently trained therapists, programmes which involve the 
training of relatives to provide therapy may be appropriate.  In this area, where there is no 
access to institutional care, the relatives already provide the day-to-day ‘nursing’ care for 
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even the most disabled stroke patients.  Currently in SSA there is a focus of effort in 
combating communicable diseases, such as HIV/AIDS.  However, as the epidemiological 
transition continues in such countries the burden of non-communicable diseases, such as 
stroke, is likely to greatly increase.[19]   
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